Format

Send to

Choose Destination
Curr Opin Genet Dev. 2006 Feb;16(1):30-7. Epub 2005 Dec 27.

Inhibition of TGFbeta signaling in cancer therapy.

Author information

1
Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. carlos.arteaga@vanderbilt.edu

Abstract

Recent evidence continues to support a central role for TGFbeta in tumor maintenance and progression. Although this may involve TGFbeta-mediated paracrine effects that modulate the tumor microenvironment and the host immune system, some studies causally implicate autocrine TGFbeta in cancer cell motility and survival. Other recent evidence indicates synergy between oncogene and TGFbeta signaling in epithelial cell transformation. This suggests opportunities for dissecting molecular mechanisms of cross-talk as well as providing insights into possible combinatorial molecular anticancer therapies that will include TGFbeta inhibitors.

PMID:
16377175
DOI:
10.1016/j.gde.2005.12.009
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center